Crescita Therapeutics Stock Today
| CRRTF Stock | USD 0.45 0.00 0.00% |
Performance9 of 100
| Odds Of DistressLess than 33
|
Crescita Therapeutics is trading at 0.45 as of the 23rd of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.45. Crescita Therapeutics has about a 33 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Crescita Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of May 2024 and ending today, the 23rd of November 2024. Click here to learn more.
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada. The company has 20.4 M outstanding shares. More on Crescita Therapeutics
Moving together with Crescita Pink Sheet
Moving against Crescita Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Crescita Pink Sheet Highlights
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Crescita Therapeutics [CRRTF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Crescita Therapeutics's market, we take the total number of its shares issued and multiply it by Crescita Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Crescita Therapeutics classifies itself under Pharmaceuticals sector and is part of Health Care industry. The entity has 20.4 M outstanding shares.
Crescita Therapeutics has accumulated about 10.5 M in cash with (1.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Crescita Therapeutics Probability Of Bankruptcy
Ownership AllocationCrescita Therapeutics holds a total of 20.4 Million outstanding shares. Crescita Therapeutics shows 7.3 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Crescita Ownership Details
Crescita Therapeutics Risk Profiles
| Mean Deviation | 62.39 | |||
| Standard Deviation | 257.33 | |||
| Variance | 66216.3 | |||
| Risk Adjusted Performance | 0.1038 |
Crescita Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Crescita Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Other Information on Investing in Crescita Pink Sheet
Crescita Therapeutics financial ratios help investors to determine whether Crescita Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crescita with respect to the benefits of owning Crescita Therapeutics security.